{"id":1089,"date":"2016-02-09T13:59:29","date_gmt":"2016-02-09T18:59:29","guid":{"rendered":"http:\/\/rohs.ca\/news\/?p=1089"},"modified":"2016-03-23T14:19:06","modified_gmt":"2016-03-23T18:19:06","slug":"proposed-scope-changes-to-eu-rohs","status":"publish","type":"post","link":"https:\/\/rohs.ca\/news\/2016\/02\/09\/proposed-scope-changes-to-eu-rohs\/","title":{"rendered":"Proposed Scope Changes to EU RoHS"},"content":{"rendered":"

Shortly after the EU RoHS 2 Directive was published in 2011, a few concerns were identified about some of the wording in RoHS 2 and its interpretation.<\/p>\n

Some manufacturers in the medical devices industry raised a concern that the use of the term “made available on the market until 22 July 2019” in referring to substance restrictions for products newly in scope of RoHS 2 will prevent those products from being refurbished and then resold after 2019. The medical equipment industry is especially impacted in that it frequently refurbishes its products and then re-sells to health care providers that can’t afford the new equipment.<\/p>\n

The language in RoHS 2 also missed an exclusion for spare parts for products that are newly in scope (other than medical devices and monitoring and control instruments).<\/p>\n

The European Commission plans to publish an amendment to the scope of the RoHS 2 Directive to address the issues. In an “<\/a>Inception Impact Assessment“<\/a> , the Commission indicates that its preferred option is to:<\/p>\n